|
Sign In to gain access to subscriptions and/or personal tools.
|
Proteinase-activated Receptor-2 (PAR2) Agonist Causes Periodontitis in Rats
M. Holzhausen1,
L.C. Spolidorio2 and
N. Vergnolle1,*
1 Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, 3330 Hospital Drive, NW, Calgary, T2N 4N1, Alberta, Canada; and
2 Department of Oral Pathology, Dental School of Araraquara, State University of São Paulo (UNESP), Araraquara, São Paulo, Brazil;
Correspondence: * corresponding author, nvergnol{at}ucalgary.ca
Proteinase-activated receptor-2 (PAR2) is a G-protein-coupled receptor that mediates cellular responses to extracellular proteinases. Since PAR2 is expressed by oral epithelial cells, osteoblasts, and gingival fibroblasts, where its activation releases interleukin-8, we hypothesized that PAR2 activation may participate in periodontal disease in vivo. We investigated the role of PAR2 activation in periodontal disease in rats. Radiographic and enzymatic (myeloperoxidase) analysis revealed that topical application of PAR2 agonist causes periodontitis but also exacerbates existing periodontitis, leading to significant alveolar bone loss and gingival granulocyte infiltration. Inhibition of matrix metalloproteinase (MMP) and cyclo-oxygenase (COX) decreased PAR2 agonist-induced periodontitis. More specifically, the overexpression of COX-1, COX-2, MMP-2, and MMP-9 in gingival tissues suggests that they are involved in PAR2-induced periodontitis. In conclusion, PAR2 agonist causes periodontitis in rats through a mechanism involving prostaglandin release and MMP activation. Inhibition of PAR2 may represent a novel approach to modulate host response in periodontitis.
Key Words: proteinase-activated receptor-2 alveolar bone loss inflammation matrix metalloproteinase cyclo-oxygenase periodontitis
Journal of Dental Research, Vol. 84, No. 2,
154-159 (2005)
DOI: 10.1177/154405910508400209

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. M. Wong, V. Tam, R. Lam, K. A. Walsh, L. Tatarczuch, C. N. Pagel, E. C. Reynolds, N. M. O'Brien-Simpson, E. J. Mackie, and R. N. Pike
Protease-Activated Receptor 2 Has Pivotal Roles in Cellular Mechanisms Involved in Experimental Periodontitis
Infect. Immun.,
February 1, 2010;
78(2):
629 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Wilson, R. Harada, L. LeDuy, M. D. Hollenberg, and A. Nepveu
CUX1 Transcription Factor Is a Downstream Effector of the Proteinase-activated Receptor 2 (PAR2)
J. Biol. Chem.,
January 2, 2009;
284(1):
36 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Dommisch, W. O. Chung, M. G. Rohani, D. Williams, M. Rangarajan, M. A. Curtis, and B. A. Dale
Protease-Activated Receptor 2 Mediates Human Beta-Defensin 2 and CC Chemokine Ligand 20 mRNA Expression in Response to Proteases Secreted by Porphyromonas gingivalis
Infect. Immun.,
September 1, 2007;
75(9):
4326 - 4333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Syeda, J. Grosjean, R. A. Houliston, R. J. Keogh, T. D. Carter, E. Paleolog, and C. P. D. Wheeler-Jones
Cyclooxygenase-2 Induction and Prostacyclin Release by Protease-activated Receptors in Endothelial Cells Require Cooperation between Mitogen-activated Protein Kinase and NF-{kappa}B Pathways
J. Biol. Chem.,
April 28, 2006;
281(17):
11792 - 11804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Holzhausen, L. C. Spolidorio, R. P. Ellen, M.-C. Jobin, M. Steinhoff, P. Andrade-Gordon, and N. Vergnolle
Protease-Activated Receptor-2 Activation: A Major Role in the Pathogenesis of Porphyromonas gingivalis Infection
Am. J. Pathol.,
April 1, 2006;
168(4):
1189 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|